advertisement

August 30th, 2008
Category:
Type 1Type 2Oral MedsInsulin & Pumps
ChildrenFoodHighs & LowsRelationships
ComplicationsEmotionsIn the NewsFitness
Women's IssuesMen's IssuesReal Life



Did any of you hear about this?


"The approach used by EpiVax is called Antigen-Specific Adaptive Tolerance Induction (ASATI) to specifically target and reduce undesirable immune responses. EpiVax used its proprietary computer algorithms to identify the molecules that induce ASATI. Because ASATI uses the body's own natural responses, this intervention has the potential to be far safer than immunosuppressive drugs that are now being studied. The promising treatment, called Epi-13, may have application to a broad range of auto-immune disorders.


EpiVax is pioneering the use of immunoinformatics for making safer, more effective human therapeutics. This approach also offers hope for individualizing therapies, also known as immuno-pharmacogenomics.


The EpiVax research program will be carried out in collaboration with Dr. David Scott of the University of Maryland and with Robert Smith of the Hallett Center for Diabetes and Endocrinology at Rhode Island Hospital. According to Dr. Smith, an expert in the treatment of Type 1 diabetes, This research deals with a critically important clinical problem and the approach EpiVax is taking in developing new diabetes therapies holds great promise."


Interesting. JDRF has given this company $351,000 for one year to provide something called proof of principle. I had to look that one up. It's a demonstration of the commercial potential of a discovery or invention.


I don't understand the ins and outs of these treatments. I know that many of them never see the light of day, failing in one way or another. I've learned not to get my hopes up. This, though, sounds interesting. I know a lot of people put a lot of stock in Dr. Faustman and her study, but in my opinion, the more studies and experiments, the better. It certainly can't hurt and if it finds a cure for another auto-immune disease but not diabetes, I'll still be thrilled. It's one less auto-immune disease out there, one step closer to a cure for diabetes.


Even though I live my life by the "I don't care if it's half-empty or half-full, I'm just glad there's a glass," principle, I do still, in the depths of my curmudgeonly little heart, hope for a cure. I just don't talk about it much. It doesn't do to pin ones heart to ones sleeve. It's far too easily bruised that way.



Login to rate
Rating (0):
1
2
3
4
5
Email this Comments (1) :: Add a comment

I say share the wealth. Whatever comes out that would either cure, or improve quality of life should be funded.


Would you like to comment?

Join dlife for a free account, or Login if you are already a member.

advertisement
Julia
Julia lives behind the Tofu Curtain, in the Pioneer Valley, in Western Massachusetts. It's a nice place. She likes it there. Her eldest daughter, Olivia, has type 1 diabetes. She's also 13. It's a real toss-up as to which is more difficult -- the diabetes or the teen-age drama. (Read More)

Latest Posts: School, Again | Back To School | Fell Off The Face Of The Earth

Michelle Kowalski
Michelle Kowalski, a writer, editor and photography hobbiest living in Phoenix, has had type 2 diabetes since February 2005. In January 2008, as part of her quest to start on an insulin pump, Michelle learned that she actually has type 1 diabetes. (Read More)

Latest Posts: Who Would You Be? | Full Disclosure? | Finding Flexibility

Our Other Bloggers: Lindsey Guerin, Rebecca Abma, Carey Potash, Kim Doty, George Simmons, Nicole Purcell, Kerri Morrone, Andy Bell, Scott Marvel
  1. Almost Better than Sex Cake
  2. Caribbean Chicken
  3. Oatmeal Raisin Cookies with Applesauce
  4. Cauliflower "Mac and Cheese"
  5. Angelic Deviled Eggs